Poxvirus vectors encoding HIV antigens, and methods of use thereof
US11723970B2 · kind B2 · utility
0Cited by
18References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 10, 2021 |
| Grant date | Aug 15, 2023 |
| Priority date | — |
| Expiry date | Jan 27, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16334
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Poxvirus vectors encoding a synthetic HIV envelope antigen and other HIV antigens, as well as compositions containing such poxvirus vectors and uses of such poxvirus vectors as vaccines to provide improved immunity against HIV, are provided. Also provided are vaccine combinations containing the disclosed poxvirus vectors, adenovirus vectors encoding one or more HIV antigens, and one or more isolated HIV antigenic polypeptides, and methods of using the vaccine combinations to provide improved immunity against HIV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.